Mesa Laboratories (NASDAQ:MLAB) Earns Underweight Rating from Analysts at Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Mesa Laboratories (NASDAQ:MLAB – Free Report) in a research note published on Tuesday, MarketBeat Ratings reports. The brokerage issued an underweight rating and a $120.00 price target on the medical instruments supplier’s stock. Separately, Evercore ISI boosted their price target on shares of Mesa Laboratories from […]

Leave a Reply

Your email address will not be published.

Previous post Choice Hotels International (NYSE:CHH) Raised to “Hold” at StockNews.com
Next post Danaher (NYSE:DHR) Now Covered by Analysts at Wells Fargo & Company